Weis Markets Q3 2026 earnings
Total revenue increased 3.0% and net income rose 31.4% to $22.21 million, supported by higher gross profit margin and operating income.
Headline numbers
| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---|---|---|
| Revenue | $1.28B | +3.0% | +0.1% | Ex. 99.1, income statement |
| EPS (GAAP) | $0.90 | +30.4% | -2.2% | Ex. 99.1, income statement |
| Net income | $22.21M | +31.4% | -2.9% | Ex. 99.1, income statement |
| Adj. EBITDA | $324.61M | +5.8% | +1.0% | Ex. 99.1, income statement |
| Adj. EBITDA margin | 25.5% | +0.7 pp | +0.7 pp | Ex. 99.1, income statement |
Revenue breakdown
not stated in the 8-K
Margins and costs
- Gross margin 25.5% (24.8% prior, +0.7 pp)
- Operating expenses $296.11M (+3.4% YoY)
- One-offs in the quarter Pharmacy pricing headwinds: $14.56M; Cyclospora outbreak impact on produce
- Effective tax rate 26.3% (prior-year 24.1%, year-to-date 25.7%)
- Non-GAAP bridge Gross profit increased 5.8% to $324.61M; operating income increased 38.6% to $28.51M.
KPIs
| Metric | Actual | Prior quarter | Prior year | Change |
|---|---|---|---|---|
| Comparable store sales | +1.3% | +2.3% | +2.3% | -1.0 pp |
| Comparable store sales (excl. fuel) | -1.2% | +2.3% | +2.3% | -3.5 pp |
| Income from operations | $28.51M | $29.11M | $20.57M | +38.6% |
Guidance
not stated in the 8-K
What drove it
- Revenue story Total revenue increased 3.0% to $1.28B, driven by higher fuel sales and sales from new stores, partially offset by lower pharmacy, dairy and produce sales.
- EPS story EPS increased 30.4% to $0.90, driven by higher net income and a lower share count.
- One-off check Pharmacy pricing headwinds related to the Inflation Reduction Act Medicare maximum fair price provisions: $14.56M
The good
- Gross profit margin increased to 25.5% from 24.8%
- Income from operations increased 38.6% to $28.51M
The bad
- Comparable store sales excluding fuel decreased 1.2%
The ugly
- none
Open questions
- The filing does not quantify the impact of the Cyclospora outbreak on produce sales.
- The filing does not quantify the impact of egg price deflation on dairy sales.
Full release
Weis Markets (WMK) earnings release, November 3, 2026
NEWS RELEASE
FOR IMMEDIATE RELEASE
Contact:
Dennis Curtin
Weis Markets, Inc.
570-847-3636 dennis.curtin@weismarkets.com
WEIS MARKETS REPORTS THIRD QUARTER 2026 RESULTS
Third Quarter 2026 total revenue increased 3.0% and comparable store sales increased 1.3%
Sunbury, PA (November 3, 2026) – Weis Markets, Inc. (NYSE: WMK) (“Weis Markets”, or the “Company”) today reported its financial results for the 13-week third quarter and 39-week year-to-date ended September 26, 2026.
“In the third quarter we delivered higher total revenue and improved earnings while customers remained cautious with their spending and continued to seek affordability and value,” said Weis Markets, Inc. Chairman, President and CEO Jonathan H. Weis. “Higher fuel sales, reflecting both retail price inflation and increased gallons sold, along with sales from new stores, supported the quarter’s total revenue increase. Inflation Reduction Act-related pharmacy pricing changes, egg price deflation and lower produce demand during the Cyclospora outbreak moderated sales performance. We continue to support our customers through price investments and an expanded loyalty marketing program.”
“Improved store inventory shrink performance and lower costs within our internal supply chain helped drive a higher gross profit margin,” said Mr. Weis. “Our people, process and technology investments continue to enhance customer value and convenience while supporting greater efficiency across our operations, including stores, supply chain, manufacturing and the Store Support Center. We are grateful to our associates for their commitment to our customers and our business.”
Third Quarter 2026 Results
Total revenue was $1.28 billion for the 13-week third quarter ended September 26, 2026, compared to $1.24 billion for the same period in 2025, a 3.0% increase. Sales growth was driven primarily by higher fuel sales and sales from new stores, partially offset by lower overall sales in pharmacy, dairy and produce. Pharmacy sales were negatively impacted by approximately $14.56 million from pricing headwinds related to the Inflation Reduction Act Medicare maximum fair price provisions, which became effective January 1, 2026, reducing total revenue growth by approximately 1.2 percentage points. Dairy sales reflected lower egg pricing compared with the prior year, and produce sales were negatively affected by lower customer demand during the Cyclospora outbreak in the third quarter. Third quarter comparable store sales increased 1.3%, while comparable store sales excluding fuel decreased 1.2%.
Third quarter gross profit increased 5.8% to $324.61 million, and gross profit margin increased to 25.5% from 24.8% in 2025. Income from operations increased 38.6% to $28.51 million. The increase in operating income more than offset lower investment income and a higher effective income tax rate.
The Company’s third quarter net income was $22.21 million compared to $16.90 million in 2025, a 31.4% increase. Based on weighted-average shares outstanding, third quarter earnings per share were $0.90 compared to $0.69 per share for the same period in 2025.
Year-To-Date 2026 Results
Total revenue was $3.81 billion for the 39-week year-to-date period ended September 26, 2026, compared to $3.66 billion for the same period in 2025, a 4.1% increase. Sales growth was driven primarily by higher fuel sales and sales from new stores, with grocery and pharmacy sales also increasing compared with the prior year. Despite higher year-to-date pharmacy sales, the category was negatively impacted by approximately $32.75 million from pricing headwinds related to the Inflation Reduction Act Medicare maximum fair price provisions, which became effective January 1, 2026, reducing total revenue growth by approximately 0.9 percentage points. Lower overall sales in dairy and produce also partially offset year-to-date sales growth. Dairy sales reflected lower egg pricing compared with the prior year, and produce sales were negatively affected by lower customer demand during the Cyclospora outbreak in the third quarter. Year-to-date comparable store sales increased 1.9%, while comparable store sales excluding fuel decreased 0.1%.
Year-to-date gross profit increased 7.8% to $983.26 million, and gross profit margin increased to 25.9% from 25.0% in 2025. Income from operations increased 28.6% to $93.31 million. Lower investment income and a higher effective income tax rate moderated the increase in net income.
The Company’s year-to-date net income totaled $72.92 million compared to $61.73 million in 2025, an 18.1% increase. Based on weighted-average shares outstanding, year-to-date earnings per share totaled $2.95 compared to $2.38 per share for the same period in 2025.
Quarterly Cash Dividend
On October 29, 2026, the Weis Markets, Inc. Board of Directors declared a quarterly cash dividend of $0.34 per share, payable on November 23, 2026, to shareholders of record as of November 9, 2026.
###
About Weis Markets
Founded in 1912, Weis Markets, Inc. is a Mid-Atlantic food retailer currently operating 201 stores in Pennsylvania, Maryland, Delaware, New Jersey, New York, West Virginia and Virginia. For more information, please visit: WeisMarkets.com or Facebook.com/WeisMarkets.
Financial statements
Income Statement
13 Weeks Ended — (Unaudited) (amounts in thousands, except shares and per share amounts)
| 13 Weeks Ended – September 26, 2026 | 13 Weeks Ended – September 27, 2025 | 39 Weeks Ended – September 26, 2026 | 39 Weeks Ended – September 27, 2025 | |
|---|---|---|---|---|
| Net sales | 1,274,817 | 1,238,208 | 3,797,393 | 3,649,492 |
| Other revenue | 4,269 | 4,099 | 12,913 | 12,387 |
| Total revenue | 1,279,086 | 1,242,307 | 3,810,306 | 3,661,879 |
| Cost of sales, including advertising, warehousing and distribution expenses | 954,472 | 935,428 | 2,827,044 | 2,750,096 |
| Gross profit on sales | 324,614 | 306,879 | 983,262 | 911,783 |
| Operating, general and administrative expenses | 296,109 | 286,313 | 889,948 | 839,207 |
| Income from operations | 28,505 | 20,566 | 93,314 | 72,576 |
| Investment income (loss) and interest expense | 2,087 | 3,276 | 7,379 | 12,981 |
| Other income (expense) | -460 | -1,565 | -2,528 | -3,370 |
| Income before provision for income taxes | 30,132 | 22,277 | 98,165 | 82,187 |
| Provision for income taxes | 7,922 | 5,374 | 25,246 | 20,458 |
| Net income | 22,210 | 16,903 | 72,919 | 61,729 |
| Weighted-average shares outstanding, basic and diluted | 24,744,597 | 24,744,597 | 24,744,597 | 25,999,035 |
| Cash dividends per share | 0.34 | 0.34 | 1.02 | 1.02 |
| Basic and diluted earnings per share | 0.9 | 0.69 | 2.95 | 2.38 |
... (truncated)y and data privacy risks, and competitive factors, including increased competition with regional and national retailers; price pressures; further expenditures related to restatement of our financial statements; and the results of any shareholder actions associated with the restatements referenced in Note 12 in the Company’s Annual Report on Form 10-K filed for the fiscal year ended December 27, 2025. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect Management’s analysis only as of the date hereof. The Company undertakes no obligation to publicly revise or update these forward-looking statements to reflect events or circumstances that arise after the date hereof. Readers should carefully review the risk factors described in other documents the Company files periodically with the Securities and Exchange Commission. Management is also providing a two-year stacked comparable store sales analysis, a non-GAAP measure, because Management believes this metric is useful to investors and analysts. It is not recommended that the two-year stacked analysis be considered a substitute for the Company’s operating results as reported in accordance with GAAP.
###